Abst#0142 at #ACR20, a post-hoc analysis of FINCH2, shows that filgotinib (FIL)(Jak1-i) + csDMARD improved the degree of activity impairment in a clinically relevant manner compared to placebo + csDMARD in pts w/ inadequate response to bDMARD . @RheumNow https://t.co/6M42LUVuht

Great #rheumtwearls #ACR20 https://t.co/HzKkhnArvr

• https://twitter.com/MeralElRamahiMD/status/1324798503793709063

ACPA in patients with RA are multireactive. How can one antibody bind to so many proteins? ACPA recognize very small linear epitopes shared by many posttranslationally modified proteins. 2F012. Antibodies in RA. #ACR20. <TK https://t.co/OUqshFoxSb

Year in review @JYazdanyMD take home points from 2 key positive trials (finally!) in SLE this year #ACR20 @RheumNow https://t.co/74SVwNavPK

#ACR20 Year in Review @JYazdanyMD presenting PEXIVAS results. The proof of efficacy equivalence and safety superiority for the low dose steroid arm is a game-changer @rheumnow https://t.co/bJ1WLL71sB

Who will be more likely to have chronic reactive arthritis @RheumNow #ACR20 @CRASCRRheum

IL-6 blockade for management of irAEs without inhibiting anti cancer immune response. Should these be given prior or concomitantly with ICIs? Some interesting ideas to look up from the cancer and immunotherapy study group. #ACR20 @UTSWNews @ACRheum @RheumNow

#ACR20 Abstr#0433 #PlenaryACR Georgia SLE registry 336 pts ⬆️stroke/isch heart dz with: 👉3X stroke risk and 24X IHD risk for black pts 👉predictors stroke: black race, DLE, renal dz 👉predictors IHD: age>65, black race, neuro & immuno d/o (e.g, APAs) @RheumNow https://t.co/u6Ky7r0FYF

Plenary session 1 no#2F011 #ACR20 @rheumnow Black #SLE patients have a 3 fold higher stroke and 24 fold higher Ishemic Heart Disease risk! https://t.co/AYtiXk7pDa

Tech support during #ACR 20 per below if needed! @RheumNow https://t.co/6OIvJDJReq

• https://twitter.com/acrheum/status/1324782359854592000

Environmental and geographical factors matter! @rheumnow #ACR20 https://t.co/uq8236Dv5r

• https://twitter.com/DrMAUrsani/status/1324748722178281474

Dr. L Calabrese excellent review of irAEs and a proposed personalized algorithm for mgmt of irAE #ACR20 @LCalabreseDO @rheumnow He believes there should be more studies combining TNFi or IL-6 with CPI https://t.co/GbvgXtNJnI

Looking forward to learning lots in the next 20mins on how to approach #telemedicine to provide better care for our patients. Important to remember to keep patients at the centre of our priorities. #rheumtwitter Session 2F05 #ACR20 @RheumNow https://t.co/aBrnytCWpu